Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance

  1. Traba, Javier
  2. Sack, Michael N.
  3. Waldmann, Thomas A.
  4. Anton, Olga M.
Revista:
Frontiers in Immunology

ISSN: 1664-3224

Año de publicación: 2021

Volumen: 12

Tipo: Artículo

DOI: 10.3389/FIMMU.2021.657293 GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Frontiers in Immunology

Resumen

Constitutive activity of the immune surveillance system detects and kills cancerous cells, although many cancers have developed strategies to avoid detection and to resist their destruction. Cancer immunotherapy entails the manipulation of components of the endogenous immune system as targeted approaches to control and destroy cancer cells. Since one of the major limitations for the antitumor activity of immune cells is the immunosuppressive tumor microenvironment (TME), boosting the immune system to overcome the inhibition provided by the TME is a critical component of oncotherapeutics. In this article, we discuss the main effects of the TME on the metabolism and function of immune cells, and review emerging strategies to potentiate immune cell metabolism to promote antitumor effects either as monotherapeutics or in combination with conventional chemotherapy to optimize cancer management.

Referencias bibliográficas

  • Hanahan, (2011), Cell, 144, 10.1016/j.cell.2011.02.013
  • Guo, (2018), Int J Biol Sci, 14, 10.7150/ijbs.25720
  • Cuezva, (2009), Biochim Biophys Acta, 1792, 10.1016/j.bbadis.2009.01.006
  • Rosenberg, (2014), J Immunol, 192, 10.4049/jimmunol.1490019
  • Ortega, (2009), Cancer Lett, 276, 10.1016/j.canlet.2008.08.007
  • Choi, (2018), Biomol Ther (Seoul), 26, pp. 19, 10.4062/biomolther.2017.178
  • Everts, (2012), Blood, 120, 10.1182/blood-2012-03-419747
  • Malinarich, (2015), J Immunol, 194, 10.4049/jimmunol.1303316
  • Rolot, (2020), Cells, 9, pp. 334, 10.3390/cells9020334
  • Akkaya, (2018), Nat Immunol, 19, 10.1038/s41590-018-0156-5
  • Wang, (2017), Sci Rep, 7, pp. 17867, 10.1038/s41598-017-18028-z
  • Kierdorf, (2015), Semin Immunol, 27, 10.1016/j.smim.2016.03.017
  • Pathria, (2019), Trends Immunol, 40, 10.1016/j.it.2019.02.003
  • Lauterbach, (2019), Immunity, 51, pp. 997, 10.1016/j.immuni.2019.11.009
  • Jha, (2015), Immunity, 42, 10.1016/j.immuni.2015.02.005
  • Tannahill, (2013), Nature, 496, 10.1038/nature11986
  • Mills, (2016), Cell, 167, pp. 457, 10.1016/j.cell.2016.08.064
  • Robb, (2018), J Biol Chem, 293, 10.1074/jbc.RA118.003647
  • Galvan-Pena, (2019), Nat Commun, 10, pp. 338, 10.1038/s41467-018-08187-6
  • Van den Bossche, (2016), Cell Rep, 17, 10.1016/j.celrep.2016.09.008
  • Millet, (2016), J Immunol, 196, 10.4049/jimmunol.1501345
  • Covarrubias, (2016), Elife, 5, pp. e11612, 10.7554/eLife.11612
  • Tan, (2015), J Immunol, 194, 10.4049/jimmunol.1402469
  • Nomura, (2016), Nat Immunol, 17, 10.1038/ni.3366
  • Vats, (2006), Cell Metab, 4, pp. 13, 10.1016/j.cmet.2006.05.011
  • Odegaard, (2007), Nature, 447, 10.1038/nature05894
  • Annunziato, (2015), J Allergy Clin Immunol, 135, 10.1016/j.jaci.2014.11.001
  • Gieseck, (2018), Nat Rev Immunol, 18, pp. 62, 10.1038/nri.2017.90
  • Wang, (2011), Immunity, 35, 10.1016/j.immuni.2011.09.021
  • Chang, (2013), Cell, 153, 10.1016/j.cell.2013.05.016
  • Akkaya, (2018), J Immunol, 201, 10.4049/jimmunol.1800753
  • Murphy, (2013), Immunity, 38, 10.1016/j.immuni.2013.02.005
  • Dang, (2011), Cell, 146, 10.1016/j.cell.2011.07.033
  • Blagih, (2015), Immunity, 42, pp. 41, 10.1016/j.immuni.2014.12.030
  • Peng, (2016), Science, 354, 10.1126/science.aaf6284
  • Angiari, (2020), Cell Metab, 31, pp. 391, 10.1016/j.cmet.2019.10.015
  • Ho, (2015), Cell, 162, 10.1016/j.cell.2015.08.012
  • Kempkes, (2019), Front Immunol, 10, 10.3389/fimmu.2019.02839
  • Oleinika, (2013), Clin Exp Immunol, 171, pp. 36, 10.1111/j.1365-2249.2012.04657.x
  • Herberman, (1975), Int J Cancer, 16, 10.1002/ijc.2910160205
  • Long, (2013), Annu Rev Immunol, 31, 10.1146/annurev-immunol-020711-075005
  • Caligiuri, (2008), Blood, 112, 10.1182/blood-2007-09-077438
  • Keppel, (2015), J Immunol, 194, 10.4049/jimmunol.1402099
  • O’Brien, (2019), Nat Rev Immunol, 19, 10.1038/s41577-019-0139-2
  • Traba, (2020), J Vis Exp, 10.3791/61466
  • Assmann, (2017), Nat Immunol, 18, 10.1038/ni.3838
  • Miranda, (2016), Mediators Inflammation, 2016, pp. 9605253, 10.1155/2016/9605253
  • Loftus, (2018), Nat Commun, 9, pp. 2341, 10.1038/s41467-018-04719-2
  • Zheng, (2019), Nat Immunol, 20, 10.1038/s41590-019-0511-1
  • Michelet, (2018), Nat Immunol, 19, 10.1038/s41590-018-0251-7
  • Mah, (2017), JCI Insight, 2, pp. e95128, 10.1172/jci.insight.95128
  • Donnelly, (2014), J Immunol, 193, 10.4049/jimmunol.1401558
  • Marcais, (2014), Nat Immunol, 15, 10.1038/ni.2936
  • Wang, (2018), Nat Commun, 9, pp. 4874, 10.1038/s41467-018-07277-9
  • Dong, (2019), Nat Immunol, 20, 10.1038/s41590-019-0388-z
  • Aghakhani, (2020), Cancers (Basel), 13, pp. 35, 10.3390/cancers13010035
  • Becker, (2020), Cell Rep, 31, pp. 107701, 10.1016/j.celrep.2020.107701
  • Fiaschi, (2012), Cancer Res, 72, 10.1158/0008-5472.CAN-12-1949
  • Francescone, (2021), Cancer Discovery, 11, 10.1158/2159-8290.CD-20-0775
  • Yang, (2016), Cell Metab, 24, pp. 685, 10.1016/j.cmet.2016.10.011
  • Gong, (2020), Cell Death Dis, 11, pp. 267, 10.1038/s41419-020-2434-z
  • Comito, (2014), Oncogene, 33, 10.1038/onc.2013.191
  • Zhang, (2019), Cell Death Dis, 10, pp. 273, 10.1038/s41419-019-1435-2
  • Komohara, (2017), J Pathol, 241, 10.1002/path.4824
  • Hirayama, (2009), Cancer Res, 69, 10.1158/0008-5472.CAN-08-4806
  • Chang, (2015), Cell, 162, 10.1016/j.cell.2015.08.016
  • Cham, (2008), Eur J Immunol, 38, 10.1002/eji.200838289
  • Carr, (2010), J Immunol, 185, 10.4049/jimmunol.0903586
  • Keating, (2016), J Immunol, 196, 10.4049/jimmunol.1501783
  • Balsamo, (2013), Eur J Immunol, 43, 10.1002/eji.201343448
  • Parodi, (2018), Front Immunol, 9, 10.3389/fimmu.2018.02358
  • Laoui, (2014), Cancer Res, 74, pp. 24, 10.1158/0008-5472.CAN-13-1196
  • Wenes, (2016), Cell Metab, 24, 10.1016/j.cmet.2016.09.008
  • Brand, (2016), Cell Metab, 24, 10.1016/j.cmet.2016.08.011
  • Fischer, (2007), Blood, 109, 10.1182/blood-2006-07-035972
  • Harmon, (2019), Cancer Immunol Res, 7, 10.1158/2326-6066.CIR-18-0481
  • Potzl, (2017), Int J Cancer, 140, 10.1002/ijc.30646
  • Errea, (2016), PloS One, 11, pp. e0163694, 10.1371/journal.pone.0163694
  • Mu, (2018), Cell Cycle, 17, 10.1080/15384101.2018.1444305
  • Colegio, (2014), Nature, 513, 10.1038/nature13490
  • Munn, (2016), Trends Immunol, 37, pp. 193, 10.1016/j.it.2016.01.002
  • Mondanelli, (2017), Curr Opin Pharmacol, 35, 10.1016/j.coph.2017.05.002
  • Della Chiesa, (2006), Blood, 108, 10.1182/blood-2006-03-006700
  • Liu, (2010), Blood, 115, 10.1182/blood-2009-09-246124
  • Frumento, (2002), J Exp Med, 196, 10.1084/jem.20020121
  • Opitz, (2011), Nature, 478, pp. 197, 10.1038/nature10491
  • Mezrich, (2010), J Immunol, 185, 10.4049/jimmunol.0903670
  • Sharma, (2009), Blood, 113, 10.1182/blood-2008-12-195354
  • Liu, (2016), Sci Rep, 6, pp. 21319, 10.1038/srep21319
  • Munn, (2005), Immunity, 22, 10.1016/j.immuni.2005.03.013
  • Metz, (2012), Oncoimmunology, 1, 10.4161/onci.21716
  • Zaiatz-Bittencourt, (2018), J Immunol, 200, 10.4049/jimmunol.1701461
  • Viel, (2016), Sci Signal, 9, pp. ra19, 10.1126/scisignal.aad1884
  • Cong, (2018), Cell Metab, 28, pp. 243, 10.1016/j.cmet.2018.06.021
  • Moo-Young, (2009), J Immunother, 32, pp. 12, 10.1097/CJI.0b013e318189f13c
  • Sato, (2011), Immunol Res, 51, 10.1007/s12026-011-8262-6
  • Ip, (2017), Science, 356, 10.1126/science.aal3535
  • Taga, (1992), J Immunol, 148, 10.4049/jimmunol.148.4.1143
  • Wang, (2016), Sci Rep, 6, pp. 24249, 10.1038/srep24249
  • Peppa, (2010), PloS Pathog, 6, pp. e1001227, 10.1371/journal.ppat.1001227
  • Robert, (2020), Nat Commun, 11, pp. 3801, 10.1038/s41467-020-17670-y
  • Rosenberg, (2008), Nat Rev Cancer, 8, pp. 299, 10.1038/nrc2355
  • Tokarew, (2019), Br J Cancer, 120, pp. 26, 10.1038/s41416-018-0325-1
  • Renner, (2019), Cell Rep, 29, pp. 135, 10.1016/j.celrep.2019.08.068
  • Zhang, (2019), Nano Lett, 19, 10.1021/acs.nanolett.8b04296
  • Triplett, (2018), Nat Biotechnol, 36, 10.1038/nbt.4180
  • Hou, (2007), Cancer Res, 67, pp. 792, 10.1158/0008-5472.CAN-06-2925
  • Prendergast, (2017), Cancer Res, 77, 10.1158/0008-5472.CAN-17-2285
  • Leone, (2019), Science, 366, 10.1126/science.aav2588
  • van Hall, (2019), J Immunother Cancer, 7, pp. 263, 10.1186/s40425-019-0761-3
  • Davis, (2015), Cancer J, 21, 10.1097/PPO.0000000000000156
  • Waldmann, (2020), Front Immunol, 11, 10.3389/fimmu.2020.00868
  • Cichocki, (2017), Cancer Res, 77, 10.1158/0008-5472.CAN-17-0799
  • Parameswaran, (2016), Nat Commun, 7, pp. 11154, 10.1038/ncomms11154
  • DeNardo, (2019), Nat Rev Immunol, 19, 10.1038/s41577-019-0127-6
  • Palmieri, (2017), Cell Rep, 20, 10.1016/j.celrep.2017.07.054
  • Gordon, (2017), Nature, 545, 10.1038/nature22396
  • Hartley, (2018), Cancer Immunol Res, 6, 10.1158/2326-6066.CIR-17-0537
  • Ding, (2015), Oncotarget, 6, 10.18632/oncotarget.5541
  • Safdie, (2009), Aging (Albany NY), 1, pp. 988, 10.18632/aging.100114
  • Raffaghello, (2008), Proc Natl Acad Sci USA, 105, 10.1073/pnas.0708100105
  • Lee, (2010), Cancer Res, 70, 10.1158/0008-5472.CAN-09-3228
  • Sun, (2017), Oncotarget, 8, 10.18632/oncotarget.20301
  • Ohta, (2016), Front Immunol, 7, 10.3389/fimmu.2016.00109
  • Orillion, (2018), Clin Cancer Res, 24, 10.1158/1078-0432.CCR-18-0980
  • Antunes, (2018), Chem Biol Interact, 281, pp. 89, 10.1016/j.cbi.2017.12.027
  • Bianchi, (2015), Oncotarget, 6, 10.18632/oncotarget.3688
  • Turbitt, (2019), Front Immunol, 10, 10.3389/fimmu.2019.01402
  • Pietrocola, (2016), Cancer Cell, 30, 10.1016/j.ccell.2016.05.016
  • Dyck, (2018), Cancer Lett, 417, pp. 11, 10.1016/j.canlet.2017.12.019
  • Michalek, (2011), J Immunol, 186, 10.4049/jimmunol.1003613
  • Aguilar, (2018), Curr Opin Immunol, 51, 10.1016/j.coi.2018.03.012
  • Manzo, (2020), J Exp Med, 217, pp. e20191920, 10.1084/jem.20191920
  • Ringel, (2020), Cell, 183, pp. 1848, 10.1016/j.cell.2020.11.009
  • Huang, (2014), Nat Immunol, 15, 10.1038/ni.2956
  • Sanchez-Jimenez, (2019), Front Oncol, 9, 10.3389/fonc.2019.00596
  • Cortellini, (2019), J Immunother Cancer, 7, pp. 57, 10.1186/s40425-019-0527-y
  • Kichenadasse, (2020), JAMA Oncol, 6, 10.1001/jamaoncol.2019.5241
  • Markle, (2014), Trends Immunol, 35, pp. 97, 10.1016/j.it.2013.10.006
  • Gupta, (2020), Proc Natl Acad Sci USA, 117, 10.1073/pnas.2003603117
  • Lecot, (2019), Front Immunol, 10, 10.3389/fimmu.2019.02155
  • Ye, (2020), Nat Commun, 11, pp. 1779, 10.1038/s41467-020-15679-x
  • Catic, (2018), Prog Mol Biol Transl Sci, 155, pp. 85, 10.1016/bs.pmbts.2017.12.003
  • Covarrubias, (2021), Nat Rev Mol Cell Biol, 22, 10.1038/s41580-020-00313-x
  • Chung, (2019), Aging Dis, 10, 10.14336/AD.2018.0324
  • Sekido, (2019), Oral Oncol, 99, pp. 104462, 10.1016/j.oraloncology.2019.104462
  • Sharma, (2006), J Immunol, 177, 10.4049/jimmunol.177.12.8348
  • Jackaman, (2013), Aging Cell, 12, 10.1111/acel.12062
  • Drijvers, (2020), Elife, 9, pp. e62420, 10.7554/eLife.62420
  • Kanesvaran, (2018), Am Soc Clin Oncol Educ Book, 38, 10.1200/EDBK_201435